Vensun Pharmaceuticals, Inc., based in Yardley, Pennsylvania, was established in July 2011 and is an emerging pharmaceutical company. Together with strategic partners, Vensun is collaboratively developing a portfolio of generic prescription products in various dosage forms covering a broad range of therapeutic categories. Through this development program, Vensun currently maintains exclusive distribution rights for 8 approved ANDA products, and more than 15 ANDA products on file with FDA pending approval. In addition, Vensun continues to pursue in-licensing opportunities commensurate with our portfolio strategy, and currently markets several products developed by partners.
